Medicare Enrolled

Dr. Denzil Etienne, M.D.

Gastroenterology · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
240 WILLOUGHBY ST STE 2, Brooklyn, NY 11201
7182508867
In practice since 2012 (14 years)
NPI: 1124389382 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Etienne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Etienne? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Etienne

Dr. Denzil Etienne is a gastroenterology specialist in Brooklyn, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Etienne performed 200 Medicare services across 159 unique beneficiaries.

Between the years covered by Open Payments, Dr. Etienne received a total of $5,231 from 32 pharmaceutical and/or device companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Etienne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 200 Medicare services $5,231 industry payments

Medicare Practice Summary

Medicare Utilization ↗
200
Medicare services
Bottom 23% in NY for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
159
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
62 $71 $170
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
57 $119 $320
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $81 $215
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $90 $270
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
15 $182 $480
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
12 $92 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,231
Total received (2018-2024)
Avg $747/year across 7 years
Top 32% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,178 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,086
2023
$1,601
2022
$1,443
2021
$437
2020
$235
2019
$285
2018
$144

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$383
Gilead Sciences, Inc.
$160
FUJIFILM Healthcare Americas Corporation
$101
Celgene Corporation
$67
Madrigal Pharmaceuticals
$59
Celltrion USA Inc.
$53
RedHill Biopharma Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Micro-tech Endoscopy USA, Inc.
$33
Daiichi Sankyo Inc.
$29
Braintree Laboratories, Inc.
$26
Janssen Biotech, Inc.
$25
Intra-Sana Laboratories
$19
Olympus America Inc.
$16
Top 3 companies account for 59.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,475
AbbVie Inc.
$503
Gilead Sciences, Inc.
$429
Janssen Biotech, Inc.
$278
AbbVie, Inc.
$208
Daiichi Sankyo Inc.
$172
Takeda Pharmaceuticals U.S.A., Inc.
$116
FUJIFILM Healthcare Americas Corporation
$101
AstraZeneca Pharmaceuticals LP
$84
Celgene Corporation
$81
Merck Sharp & Dohme Corporation
$77
RedHill Biopharma Inc.
$64
Madrigal Pharmaceuticals
$59
Celltrion USA Inc.
$53
Olympus America Inc.
$51
Braintree Laboratories, Inc.
$50
Cook Medical LLC
$48
STERIS CORPORATION
$46
PFIZER INC.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Micro-tech Endoscopy USA, Inc.
$33
W. L. Gore & Associates, Inc.
$25
Shire North American Group Inc
$24
AIMMUNE THERAPEUTICS, INC.
$24
Covidien LP
$23
Nestle HealthCare Nutrition Inc.
$23
Otsuka America Pharmaceutical, Inc.
$22
CapsoVision, Inc.
$22
Intra-Sana Laboratories
$19
Echosens North America, Inc.
$18
Alcresta Therapeutics, Inc.
$17
Boston Scientific Corporation
$14
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
BREATHTEK · Bravo · CREON · CYLTEZO · CapsoCam Plus · DIFICID · ENTYVIO · EVIS EXERA III COLONOVIDEOSCOPE · Epclusa · FUJIFILM · FibroScan · GATTEX · GORE CARDIOFORM Septal Occluder · HEMOSPRAY · HUMIRA · Humira · INJECTAFER · Instinct · LINZESS · Lockado · MAVYRET · Mavyret · PREVNAR - 13 · RELIZORB · RELTONE 200 MG · REMICADE · RESMETIROM · RINVOQ · Roth Net Retriever 360 · Roth Net Retrievers · SKYRIZI · SPYGLASS · SUTAB · TREMFYA · Talicia · VISIGLIDE · VOWST · XELJANZ · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA · eyeMAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Brooklyn?
Compare gastroenterologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
1,213
Per 100K population
45.8
County median income
$78,548
Nearest hospital
BROOKLYN HOSPITAL CENTER - DOWNTOWN CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Etienne is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Etienne experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Etienne performed 62 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Etienne receive payments from pharmaceutical companies?
Yes. Dr. Etienne received a total of $5,231 from 32 companies across 154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Etienne's costs compare to other gastroenterologists in Brooklyn?
Dr. Etienne's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Etienne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →